Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the
identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 …

Purpose CDK4 is amplified in> 90% of well-differentiated (WDLS) and dedifferentiated
liposarcomas (DDLS). The selective cyclin-dependent kinase 4 (CDK4)/CDK6 inhibitor …

Abstract Treatment with immune checkpoint inhibitors (ICI) has demonstrated clinical benefit
for a wide range of cancer types. Because only a subset of patients experience clinical …

Objective: To determine the prognostic significance of histologic type/subtype in a large
series of patients with primary resected retroperitoneal sarcoma. Background: The histologic …

In multiple cancer types, high tumor mutational burden (TMB) is associated with longer
survival after treatment with immune checkpoint inhibitors (ICIs). The association of TMB with …

Objective: To construct a postoperative nomogram to estimate the risk of local recurrence for
patients with desmoid tumors. Background: The standard management of desmoid tumors …

Importance More than 90% of well-differentiated or dedifferentiated liposarcomas (WD/DDLS)
haveCDK4amplification. The selectiveCDK4andCDK6inhibitor palbociclib inhibits growth …

Although complete surgical resection is currently the most effective treatment for WDLS and
DDLS, the majority of patients with retroperitoneal liposarcoma will eventually have …

The genetic, biologic, and clinical heterogeneity of sarcomas poses a challenge for the
identification of therapeutic targets, clinical research, and advancing patient care. Because there …

CTNNB1 mutations or APC abnormalities have been observed in ∼85% of desmoids examined
by Sanger sequencing and are associated with Wnt/β‐catenin activation. We sought to …